SAS GROUPE SYNERLAB is a company operating in the pharmaceutical industry.
Groupe SYNERLAB (CDMO) generate a turnover of 130 million euros in 2018 and operate 6 factories in Europe. SYNERLAB currently employ over 1 000 people and are dedicated to pharmaceutical development and manufacturing.Groupe SYNERLAB offer solutions for analytical and galenical development, manufacturing and packaging of medicinal products for human, veterinary use, medical devices and food supplements in various dosage forms, especially for solid and liquid oral form, non-injectable sterile liquids and custom freeze-drying.
Company type
Products and services
Contract Services – Analytical & Lab Services, Pharmaceutical Machinery & Technology
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with SAS GROUPE SYNERLAB on LinkedIn
Address
SAS GROUPE SYNERLAB, 3, rue du Tonnelier , Aeroparc 3, Entzheim, France, 67960